In Vivo Depiction Of Bone Vascularization With UHR-CT CT And Deep Learning Algorithm Reconstruction: A Preliminary Study

Sponsor
Central Hospital, Nancy, France (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05628792
Collaborator
(none)
20
3.3

Study Details

Study Description

Brief Summary

To evaluate the image quality and ability to depict in vivo bone vascularization with an ultra-high-resolution computed tomography (UHR-CT) scanner using a deep learning reconstruction (DLR) and hybrid iterative reconstruction (HIR) algorithms, compared to simulated conventional CT, using osteoid osteoma (OO) as a model.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: CT

Study Design

Study Type:
Observational
Anticipated Enrollment :
20 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
In Vivo Depiction Of Bone Vascularization With UHR-CT CT And Deep Learning Algorithm Reconstruction: A Preliminary Study
Anticipated Study Start Date :
Dec 20, 2022
Anticipated Primary Completion Date :
Jan 31, 2023
Anticipated Study Completion Date :
Mar 31, 2023

Outcome Measures

Primary Outcome Measures

  1. Number of cortical vessels [Retrospective review of all ultra high resolution CT of the precedent 2 years]

    Number

  2. Number of nidus vessels [Retrospective review of all ultra high resolution CT of the precedent 2 years]

    Number

Secondary Outcome Measures

  1. Confidence Score [Retrospective review of all ultra high resolution CT of the precedent 2 years]

    1 (weak) to 5 (strong)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Proven osteoid osteoma

  • Ultra High Resolution CT

Exclusion Criteria:
  • None

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Central Hospital, Nancy, France

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
GILLET Romain, MD, MSK Radiologist, Central Hospital, Nancy, France
ClinicalTrials.gov Identifier:
NCT05628792
Other Study ID Numbers:
  • N°2-RCB/EUDRACT
First Posted:
Nov 29, 2022
Last Update Posted:
Nov 29, 2022
Last Verified:
Nov 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by GILLET Romain, MD, MSK Radiologist, Central Hospital, Nancy, France
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 29, 2022